Breakout Labs
37
585K
30
3.36
3
0.14
1
- Stages of investment
- Areas of investment
Summary
Breakout Labs appeared to be the VC, which was created in 2013. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the San Francisco.
Besides them, we counted 2 critical employees of this fund in our database.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Breakout Labs, startups are often financed by SOSV, Innovation Works, Urban Redevelopment Authority of Pittsburgh. The meaningful sponsors for the fund in investment in the same round are StartX (Stanford-StartX Fund), Partnership Fund for New York City, National Science Foundation. In the next rounds fund is usually obtained by Dolby Family Ventures, Breakout Ventures, Takeda Ventures.
Among the most popular portfolio startups of the fund, we may highlight Modern Meadow, C2Sense, Azitra. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Chemical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Opposing the other organizations, this Breakout Labs works on 23 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2019. Deals in the range of 100 thousands - 1 million dollars are the general things for fund. Considering the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2016.
Investments analytics
Analytics
- Total investments
- 37
- Lead investments
- 3
- Exits
- 1
- Rounds per year
- 3.36
- Follow on index
- 0.14
- Investments by industry
- Biotechnology (16)
- Health Care (8)
- Medical (6)
- Nanotechnology (5)
- Therapeutics (5) Show 38 more
- Investments by region
-
- United States (33)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 133K
- Group Appearance index
- 0.32
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| 07 Mar 2019 | Seed | 500K | |||
| Risika | 01 May 2021 | Software, FinTech, Information Technology, Information Services, SaaS, Big Data, Business Intelligence, Credit, Database, Risk Management | Seed | 791K | Hovedstaden, Copenhagen, Denmark |
| Siva Therapeutics | 20 Dec 2013 | Biotechnology, Medical Device, Therapeutics | Seed | 400K | United States, Boulder, Colorado |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.